The iconic status of Viagra, and its parent firm copyright, presents a challenging question for shareholders . While earnings initially surged, the looming patent lapse and rising generic rivalry represent https://caoimhecwrw587144.free-blogz.com/89109277/the-blue-pill-and-pharma-a-risky-investment